Home › Funds › EMERALD ADVISERS, LLC › MIRM
EMERALD ADVISERS, LLC position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
EMERALD ADVISERS, LLC reported holding 469,771 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$40.2M, representing 1.10% of its reported portfolio and ranking #31 among its reported holdings. EMERALD ADVISERS, LLC has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EMERALD ADVISERS, LLC's MIRM position evolved
EMERALD ADVISERS, LLC first disclosed a stake in MIRM in Q2 2025 at 305,766 shares (US$15.6M). The position peaked in Q2 2026 at 468,295 shares, worth US$54.8M. Across 6 filings, EMERALD ADVISERS, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 469,771 shares valued at US$40.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 305.77K | $15.56M | New |
| Q3 2025 | 369.60K | $27.10M | Add |
| Q4 2025 | 367.13K | $29.00M | Reduce |
| Q1 2026 | 397.26K | $36.70M | Add |
| Q2 2026 | 468.30K | $54.82M | Add |
| Q3 2026 | 469.77K | $40.16M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K sh · $52.21M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K sh · $48.66M · Q2 2026
- Palo Alto Investors LP 348.81K sh · $40.83M · Q2 2026
More on EMERALD ADVISERS, LLC
FAQ
How long has EMERALD ADVISERS, LLC held MIRM?
EMERALD ADVISERS, LLC has disclosed MIRM holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is EMERALD ADVISERS, LLC's current position in MIRM?
As of Q3 2026, EMERALD ADVISERS, LLC holds 469.77K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $40.16M, representing 1.10% of its reported portfolio and ranking #31.
Has EMERALD ADVISERS, LLC been buying or selling MIRM?
In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC held unchanged its position in MIRM. The position peaked in Q2 2026 at 468.30K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.